HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

TRISTAR SALES FALL 8.4% TO $15 MIL. IN FIRST QUARTER

This article was originally published in The Rose Sheet

Executive Summary

TRISTAR SALES FALL 8.4% TO $15 MIL. IN FIRST QUARTER ended Nov. 30, the company said in a Dec. 23 statement of operating results. Tristar attributed the sales decline to "completion of the transfer of customers outside the company's exclusive marketing area to the company's major supplier, as well as to lower sales into Mexico due to economic conditions and the continued disruption of border traffic." The company added that "to a lesser extent, net sales were lower due to continued weak economies in our markets in the U.S. and Canada and competitive pressures."

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS000027

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel